vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, type 2 - legemidler som brukes i diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgjengelige data på forskjellige kombinasjoner).
nycoplus magnesium 120 mg -
orifarm healthcare a/s - magnesiumlaktatdihydrat / magnesiumsitratpentahydrat - tyggetablett
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgjengelige data på forskjellige kombinasjoner).
novaluzid
viatris as - aluminiumhydroksid / magnesiumhydroksid / magnesiumsubkarbonat - tyggetablett
pepcidduo
mcneil sweden ab - famotidin / magnesiumhydroksid / kalsiumkarbonat - tyggetablett med spearmintsmak - 10 mg / 165 mg / 800 mg
eucreas
novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
zomarist
novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - legemidler som brukes i diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.
addex-magnesium 1 mmol/ ml
fresenius kabi norge as - halden - magnesiumsulfatheptahydrat - konsentrat til infusjonsvæske, oppløsning - 1 mmol/ ml
onivyde pegylated liposomal (previously known as onivyde)
les laboratoires servier - irinotecan anhydrous free-base - bukspyttkjertelblodsykdommer - antineoplastiske midler - behandling av metastatisk adenocarcinoma av bukspyttkjertelen, sammen med 5 fluorouracil (5 fu) og leucovorin (lv), i voksen pasienter som har kommet etter gemcitabine basert terapi.
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - karsinom, ikke-småcellet lunge - antineoplastiske midler - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.